Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
990.2 INR | -0.73% | +5.53% | +30.40% |
Sales 2024 * | 63.38B 760M 60.85B | Sales 2025 * | 70.38B 844M 67.58B | Capitalization | 195B 2.33B 187B |
---|---|---|---|---|---|
Net income 2024 * | 5.92B 70.97M 5.68B | Net income 2025 * | 7.03B 84.31M 6.75B | EV / Sales 2024 * | 3.11 x |
Net Debt 2024 * | 2.62B 31.39M 2.51B | Net cash position 2025 * | 457M 5.49M 439M | EV / Sales 2025 * | 2.76 x |
P/E ratio 2024 * |
32.8
x | P/E ratio 2025 * |
27.6
x | Employees | 14,593 |
Yield 2024 * |
0.9% | Yield 2025 * |
1.02% | Free-Float | 29.28% |
Latest transcript on Alembic Pharmaceuticals Limited
1 day | -0.73% | ||
1 week | +5.53% | ||
Current month | +0.55% | ||
1 month | +0.56% | ||
3 months | +5.16% | ||
6 months | +32.52% | ||
Current year | +30.40% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 76 | 30/04/83 | |
Director of Finance/CFO | 64 | 17/01/03 | |
Manisha Saraf
CMP | Compliance Officer | - | 31/03/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 76 | 30/04/83 | |
Director of Finance/CFO | 64 | 17/01/03 | |
Director/Board Member | 56 | 03/02/15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.00% | 117 M€ | +1.11% | - | |
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 990.2 | -0.73% | 274,350 |
25/04/24 | 997.5 | +4.12% | 136,404 |
24/04/24 | 958 | +1.89% | 60,861 |
23/04/24 | 940.2 | -1.24% | 57,145 |
22/04/24 | 952.1 | +1.47% | 61,662 |
Delayed Quote NSE India S.E., April 26, 2024 at 12:43 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.40% | 2.33B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- APLLTD Stock